Forest Laboratories Inc. v. Mylan Pharmaceuticals Inc.
1:14-cv-00508
Overview
Parties
Defendant
Amneal Pharmaceuticals of New York, LLC Operating Company
Represented By
2 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Amerigen Pharmaceuticals Inc. Operating Company
Represented By
1 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Mylan Pharmaceuticals Inc. Operating Company
Represented By
5 Attorneys ListedPhillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Phillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Plaintiff
Merz Pharmaceuticals GmbH NPE (Individual / Inventor)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Merz Pharma GmbH & Co. KGaA Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Forest Laboratories Holdings Ltd. NPE (Patent Assertion Entity)
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Forest Laboratories Inc. Operating Company
Represented By
4 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Counter Claimant
Amerigen Pharmaceuticals Ltd. Operating Company
Represented By
6 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Amneal Pharmaceuticals LLC Operating Company
Represented By
6 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Smith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Amneal Pharmaceuticals of New York LLC Operating Company
Represented By
2 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Smith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
Counter Defendant
Adamas Pharmaceuticals Inc. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 5,061,703 Asserted | Asserted Patent | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 89,106,657 | European Counterpart (EP) | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 392,059 B1 | European Counterpart (EP) | View Official Patent → |
Forest Laboratories Inc. v. Orgenus Pharma Inc.
Forest Laboratories Inc. v. Dr. Reddy's Laboratories Inc.
Forest Laboratories Inc. v. Lupin Pharmaceuticals Inc.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5061703
Adamantane derivatives in the prevention and treatment of cerebral ischemia
|
Filed: 1990-04-11
Issued: 1991-10-29
|
Expired (Term Ended)
+1826d PTA
Expires: 2015-04-11
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+1826 days) / Cellect Scrutiny — Over 1826 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
57
Dispositive
15
Granted
0
Denied
3
Pending / Review
52
Motions by Category
Key Dispositive Motions & Rulings